Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ishita Drugs And Industries's total inventories for the quarter that ended in Mar. 2026 was ₹9.2 Mil. Ishita Drugs And Industries's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was ₹4.6 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Ishita Drugs And Industries's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹23.45.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Ishita Drugs And Industries's Days Inventory for the
three
months ended in Mar. 2026 was 18.48.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ishita Drugs And Industries's Inventory Turnover for the quarter that ended in Mar. 2026 was 4.94.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ishita Drugs And Industries's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.15.
Ishita Drugs And Industries (BOM:524400) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Ishita Drugs And Industries's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ishita Drugs And Industries's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Ishita Drugs And Industries Total Inventories Related Terms
Ishita Drugs And Industries Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ishita Drugs And Industries Total Inventories Chart
Ishita Drugs And Industries Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Ishita Drugs And Industries (BOM:524400) has a Total Inventories of ₹9.2 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Ishita Drugs And Industries and its competitors.
Is Ishita Drugs And Industries' Total Inventories too high?
Ishita Drugs And Industries' current Total Inventories is ₹9.2 Mil. Overall, Ishita Drugs And Industries has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ishita Drugs And Industries' Total Inventories compare to ZTS and UTHR?
Ishita Drugs And Industries' Total Inventories of ₹9.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Ishita Drugs And Industries and its competitors. Ishita Drugs And Industries's current Total Inventories is ₹9.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ishita Drugs And Industries stock overvalued right now?
Based on GuruFocus' analysis, Ishita Drugs And Industries (BOM:524400) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.36, compared to a current price of ₹71.79 — trading 8.4% below its estimated fair value. The current Total Inventories is ₹9.2 Mil. Ishita Drugs And Industries' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Ishita Drugs And Industries (BOM:524400), the current Total Inventories is ₹9.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ishita Drugs And Industries (BOM:524400) Overvalued in 2026?
Based on GuruFocus' analysis, Ishita Drugs And Industries stock appears to be undervalued.
The current stock price of ₹71.79 is trading 8.4% below its estimated GF Value™ of ₹78.36.
GuruFocus considers Ishita Drugs And Industries to be Fairly Valued.
Key valuation signals for BOM:524400:
Total Inventories: ₹9.2 Mil
GF Value™: ₹78.36 vs. price of ₹71.79 (8.4% below fair value)
No single metric tells the full story. See the BOM:524400 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
73GF Score
Get the complete analysis for BOM:524400
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524400 has been successfully added to your 
